ClinicalTrials.govpublic full text
Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs
myeloma, venous thromboembolism, antixa anticoagulant, venous thromboembolic disease, imids, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 875194
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.